E. Del Duca - Icahn School of Medicine at Mount Sinai, New York, New York, United States

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Upadacitinib treatment of atopic dermatitis patients leads to reductions in epidermal hyperplasia and cellular infiltrates

T. Song,A. Pavel,X. Peng,E. Del Duca,Y. Estrada, K. Grebe,J. Parmentier, H. Teixeira,L. Beck, E. Guttman-Yassky

Journal of Investigative Dermatology（2023）

引用3浏览0引用

Transitions in blood immune profile in atopic dermatitis from infancy to adulthood

E. Del Duca,Y. Renert-Yuval,A. Pavel, D. Mikhaylov,R. Lefferdink, M. Fang, A. Sheth, P. Facheris,J. Wu, Y. Estrada,S. Rangel,J. Krueger,

JOURNAL OF INVESTIGATIVE DERMATOLOGYno. 5 (2023): S94-S94

引用0浏览0引用

371 The OX40/OX40L axis plays a key role in treg dysfunction in atopic dermatitis

D. Dahabreh, K. Yamamura, D. Lozano-Ojalvo,E. Del Duca, M. Yamamura, S. Garcet,J. Gonzalez, S. Miura,S. Williams, X. Li, H. Beom Hur, Y. Estrada,

Journal of Investigative Dermatology（2023）

引用0浏览0引用

Ritlecitinib, an oral dual JAK3/TEC family kinase inhibitor, induces differential changes in immunological protein levels across Fitzpatrick skin types (FST) in patients with active nonsegmental vitiligo (NSV)

E. Peeva,Y. Yamaguchi,Z. Ye,B. King,M. Picardo,A. Sloan,K. Ezzedine,E. Del Duca,Y. Estrada,M. Hassan-Zahraee,W. He,C. Hyde,

Journal of Investigative Dermatologyno. 5 (2023): S208-S208

引用0浏览0引用

1187 Ritlecitinib, an oral JAK3/TEC family kinase inhibitor, reduces immune biomarkers in active lesions and increases melanocyte products in stable lesions in patients with non-segmental vitiligo (NSV)

E. Guttman-Yassky, E. Peeva,E. Del Duca, P. Facheris, J. Bar, R.N. Shore, L.A. Cox, A. Sloan, D. Thaçi, A. Ganeson, G. Han, K. Ezzedine,

Journal of Investigative Dermatology（2023）

引用0浏览0引用

1312 Heterogeneities in proteomic profiles among African American and East African patients with atopic dermatitis

D. Liu,E. Del Duca,Y. Renert-Yuval, C. Lang, H. Kaderbhai,G. Semango,M. Brüggen, J. Krueger, J. Masenga, E. Guttman-Yassky

Journal of Investigative Dermatologyno. 5 (2023): S225-S225

引用0浏览0引用

031 Tape strips better capture epidermal barrier abnormalities of patients with atopic dermatitis compared to skin biopsies

A.D. Pagan,J. Cheng,E. Del Duca,A.B. Pavel, J.G. Krueger,R. Bissonnette, E. Guttman-Yassky

Journal of Investigative Dermatology（2022）

引用0浏览0引用

299 Oral difelikefalin improves itch and inflammatory biomarkers in atopic dermatitis subjects with moderate-to-severe pruritus

E. Guttman-Yassky, P. Facheris,J. Correa Da Rosa,E. Del Duca, Y. Estrada,E. David,A. Pavel,S. Bose,J. Goncalves, K. Nograles,B. Kim,M. Lebwohl

Journal of Investigative Dermatology（2022）

引用1浏览0引用

440 Topical phosphodiesterase 4 (PDE4) inhibitor crisaborole (crisa) improves skin transcriptomic and proteomic biomarkers of mild-to-moderate AD towards normal skin

A. Pavel,E. Del Duca,J. Cheng, P. Facheris, Y. Estrada, A. Cha, J. Werth, R. Bissonette, K. Nocka,C. Zang, E. Guttman-Yassky

Journal of Investigative Dermatology（2022）

引用0浏览0引用

Tape-strips capture gene-expression changes in moderate-to-severe atopic dermatitis patients treated with dupilumab

D. Mikhaylov,E. Del Duca,C. Meyer Olesen,H. He, J. Wu,B. Ungar,Y. Estrada, N. Zhang,M. Chowdhury,M. Clausen,J. G. Krueger, A. B. Pavel,

Journal of Investigative Dermatology（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn